Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Latest News about ImmunoGen Inc
Recent news which mentions ImmunoGen Inc
Cramer's Lighting Round: Arm is 'one you want to own'
January 05, 2024
Tags
Investing
Business News
World Wrestling Entertainment Inc
From
CNBC.com News
Cramer names biopharma companies to watch as industry mergers start to pile up
January 05, 2024
Tags
stocks
Stock markets
Business
From
CNBC.com News
5 things to know before the stock market opens Thursday
December 07, 2023
Tags
5 Things to Know
Business News
Economy
From
CNBC.com News
Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion
November 30, 2023
Tags
ImmunoGen Inc
Biotech and Pharmaceuticals
Merck & Co Inc
From
CNBC.com News
Cramer's Lightning Round: Sell Immunogen and take the gain
June 09, 2023
Tags
Investing
U/S/ Markets
Ameriprise Financial Inc
From
CNBC.com News
Stocks making the biggest moves midday: Palo Alto Networks, 3M, Amedisys, Target and more
June 05, 2023
Tags
Dollar General Corp
Palo Alto Networks Inc
Finance
From
CNBC.com News
Stocks making the biggest moves midday: CVS Health, Eli Lilly, Clorox, Yum and more
May 03, 2023
Tags
ImmunoGen Inc
Starbucks Corp
Markets
From
CNBC.com News
Stocks making the biggest moves midday: Netflix, Cal-Maine Foods, Southwest and more
December 29, 2022
Tags
TG Therapeutics Inc
Tesla Inc
ImmunoGen Inc
From
CNBC.com News
Stocks making the biggest moves premarket: Tesla, Cal-Maine, Southwest and others
December 29, 2022
Tags
Stock markets
Breaking News: Markets
Lockheed Martin Corp
From
CNBC.com News
Cramer's lightning round: I still see another bad quarter ahead for Ford Motor
November 22, 2022
Tags
stocks
Markets
Mad Money
From
CNBC.com News
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.